Acetylcholine receptor autoantibody secretion by thymocytes: Relationship to myasthenia gravis

Hiroaki Yoshikawa, Vanda A Lennon

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We tested thymus cells from 119 patients with acquired myasthenia gravis (MG) for in vitro production of acetylcholine receptor (AChR) binding antibodies (Ab); 109 were seropositive, of which 82 (75%) secreted AChRAb in vitro. As noted in earlier studies, thymus cell secretion of AChRAb paralleled serum Ab levels (p(s) = 0.503;p < 0.0001; n = 119). Striational Ab secretion also correlated with the patients' serologic status. AChRAb secretion in vitro predicted the secretory activity of thymus cells implanted in severe combined immune deficiency (SCID) mice. Thymocytes from patients treated with corticosteroids made significantly less AChRAb than thymocytes from untreated patients (p < 0.005). Of particular note: (1) AChRAb was secreted by thymocytes from two of five nonimmunosuppressed patients who had generalized MG but who were seronegative for AChR binding autoantibodies; and (2) AChRAb secretion from both thymic and nonthymic sources was documented in a patient with noninvasive thymoma whose first signs of MG appeared 7 months after thymectomy. We conclude that the thymus in a majority of patients with acquired MG is the principal but not the sole reservoir of immunocytes that specifically react with muscle antigens.

Original languageEnglish (US)
Pages (from-to)562-567
Number of pages6
JournalNeurology
Volume49
Issue number2
StatePublished - Aug 1997

Fingerprint

Myasthenia Gravis
Cholinergic Receptors
Thymocytes
Autoantibodies
Thymus Gland
Antibodies
Severe Combined Immunodeficiency
Thymectomy
Thymoma
Adrenal Cortex Hormones
Antigens
Muscles
Serum
In Vitro Techniques

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Acetylcholine receptor autoantibody secretion by thymocytes : Relationship to myasthenia gravis. / Yoshikawa, Hiroaki; Lennon, Vanda A.

In: Neurology, Vol. 49, No. 2, 08.1997, p. 562-567.

Research output: Contribution to journalArticle

@article{5c5067a4c4024f778fdc2413b97eee78,
title = "Acetylcholine receptor autoantibody secretion by thymocytes: Relationship to myasthenia gravis",
abstract = "We tested thymus cells from 119 patients with acquired myasthenia gravis (MG) for in vitro production of acetylcholine receptor (AChR) binding antibodies (Ab); 109 were seropositive, of which 82 (75{\%}) secreted AChRAb in vitro. As noted in earlier studies, thymus cell secretion of AChRAb paralleled serum Ab levels (p(s) = 0.503;p < 0.0001; n = 119). Striational Ab secretion also correlated with the patients' serologic status. AChRAb secretion in vitro predicted the secretory activity of thymus cells implanted in severe combined immune deficiency (SCID) mice. Thymocytes from patients treated with corticosteroids made significantly less AChRAb than thymocytes from untreated patients (p < 0.005). Of particular note: (1) AChRAb was secreted by thymocytes from two of five nonimmunosuppressed patients who had generalized MG but who were seronegative for AChR binding autoantibodies; and (2) AChRAb secretion from both thymic and nonthymic sources was documented in a patient with noninvasive thymoma whose first signs of MG appeared 7 months after thymectomy. We conclude that the thymus in a majority of patients with acquired MG is the principal but not the sole reservoir of immunocytes that specifically react with muscle antigens.",
author = "Hiroaki Yoshikawa and Lennon, {Vanda A}",
year = "1997",
month = "8",
language = "English (US)",
volume = "49",
pages = "562--567",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Acetylcholine receptor autoantibody secretion by thymocytes

T2 - Relationship to myasthenia gravis

AU - Yoshikawa, Hiroaki

AU - Lennon, Vanda A

PY - 1997/8

Y1 - 1997/8

N2 - We tested thymus cells from 119 patients with acquired myasthenia gravis (MG) for in vitro production of acetylcholine receptor (AChR) binding antibodies (Ab); 109 were seropositive, of which 82 (75%) secreted AChRAb in vitro. As noted in earlier studies, thymus cell secretion of AChRAb paralleled serum Ab levels (p(s) = 0.503;p < 0.0001; n = 119). Striational Ab secretion also correlated with the patients' serologic status. AChRAb secretion in vitro predicted the secretory activity of thymus cells implanted in severe combined immune deficiency (SCID) mice. Thymocytes from patients treated with corticosteroids made significantly less AChRAb than thymocytes from untreated patients (p < 0.005). Of particular note: (1) AChRAb was secreted by thymocytes from two of five nonimmunosuppressed patients who had generalized MG but who were seronegative for AChR binding autoantibodies; and (2) AChRAb secretion from both thymic and nonthymic sources was documented in a patient with noninvasive thymoma whose first signs of MG appeared 7 months after thymectomy. We conclude that the thymus in a majority of patients with acquired MG is the principal but not the sole reservoir of immunocytes that specifically react with muscle antigens.

AB - We tested thymus cells from 119 patients with acquired myasthenia gravis (MG) for in vitro production of acetylcholine receptor (AChR) binding antibodies (Ab); 109 were seropositive, of which 82 (75%) secreted AChRAb in vitro. As noted in earlier studies, thymus cell secretion of AChRAb paralleled serum Ab levels (p(s) = 0.503;p < 0.0001; n = 119). Striational Ab secretion also correlated with the patients' serologic status. AChRAb secretion in vitro predicted the secretory activity of thymus cells implanted in severe combined immune deficiency (SCID) mice. Thymocytes from patients treated with corticosteroids made significantly less AChRAb than thymocytes from untreated patients (p < 0.005). Of particular note: (1) AChRAb was secreted by thymocytes from two of five nonimmunosuppressed patients who had generalized MG but who were seronegative for AChR binding autoantibodies; and (2) AChRAb secretion from both thymic and nonthymic sources was documented in a patient with noninvasive thymoma whose first signs of MG appeared 7 months after thymectomy. We conclude that the thymus in a majority of patients with acquired MG is the principal but not the sole reservoir of immunocytes that specifically react with muscle antigens.

UR - http://www.scopus.com/inward/record.url?scp=0030766642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030766642&partnerID=8YFLogxK

M3 - Article

C2 - 9270597

AN - SCOPUS:0030766642

VL - 49

SP - 562

EP - 567

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 2

ER -